These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2182479)

  • 1. The serotonergic mechanisms are not involved in the inhibitory effect of captopril on rat platelet aggregation.
    Malinowska B; Chabielska E; Pietraszek MH; Buczko W
    Haemostasis; 1990; 20(1):48-53. PubMed ID: 2182479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of 5-hydroxytryptamine in platelet aggregation in vivo in rats and guinea pigs.
    Smith GM
    Thromb Haemost; 1989 Jun; 61(3):463-7. PubMed ID: 2799759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of captopril on serotonergic mechanisms in two-kidney, one-clip renal hypertensive rats.
    Morelowska D; Chabielska E; Pawlak D; Azzadin A; Białkowska A; Krygicz D; Buczko W
    Pol J Pharmacol Pharm; 1992; 44(4):365-72. PubMed ID: 1287600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ethanol on some serotonergic mechanisms in rat blood platelets.
    Chabielska E; Pietraszek M; Malinowska B; Buczko W
    Pol J Pharmacol Pharm; 1988; 40(3):241-9. PubMed ID: 3241765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of verapamil on serotonergic mechanisms in the rat blood platelets.
    Pietraszek M; Chabielska E; Malinowska B; Buczko W
    Pol J Pharmacol Pharm; 1988; 40(1):81-6. PubMed ID: 3237561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP plays a key role in thrombogenesis in rats.
    Maffrand JP; Bernat A; Delebassée D; Defreyn G; Cazenave JP; Gordon JL
    Thromb Haemost; 1988 Apr; 59(2):225-30. PubMed ID: 3133809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
    Bevan J; Heptinstall S
    Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human platelets in vitro.
    De Clerck F; Xhonneux B
    Agents Actions; 1986 Mar; 17(5-6):515-26. PubMed ID: 2939698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acetaldehyde on some serotonergic mechanisms in rat blood platelets.
    Pawlak D; Chabielska E; Buczko W
    Pol J Pharmacol; 1993; 45(1):59-66. PubMed ID: 8401760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ethanol and serotonin on rat platelet aggregation.
    Chabielska E; Malinowska B; Buczko W
    Pharmacology; 1990; 40(5):288-92. PubMed ID: 2274574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-induced platelet aggregation:--evidence against the essential role of platelet adenosine diphosphate.
    Nunn B
    Thromb Haemost; 1979 Dec; 42(4):1193-206. PubMed ID: 542929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
    Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G
    Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
    Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
    Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of verapamil on platelet aggregation.
    Glusa E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):469-73. PubMed ID: 2465955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
    Thorsen T; Lie RT; Holmsen H
    Undersea Biomed Res; 1989 Nov; 16(6):453-64. PubMed ID: 2603242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A affects serotonergic mechanisms in uremic rats.
    Krygicz D; Azzadin A; Pawlak R; Małyszko JS; Pawlak D; Myśliwiec M; Buczko W
    Pol J Pharmacol; 1996; 48(3):351-4. PubMed ID: 9112676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in humans.
    De Clerck F; Xhonneux B
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S23-5. PubMed ID: 2412050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.